D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, 4D ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

Clinically meaningful lung function activity, measured by ppFEV1 and LCI2.5,with follow-up through 1 year at dose selected for Phase 2 Durable ...

EMERYVILLE, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Memory swizzling is the quiet tax that every hierarchical-memory accelerator pays. It is fundamental to how GPUs, TPUs, NPUs, ...

Framed around advances in technology, design, product strategy and brand ambition, the event outlined a comprehensive upgrade of the marque.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy ...

Rates on savings accounts have held steady from a week ago. You can now earn as much as 5.84% on your savings. In the market ...

Kase reports a retail supply chain shift by 2026, driven by tariffs and tech gaps, prioritizing regionalization and ...

Look for IonQ to continue pursuing attractive opportunities in 2026. One deal is already on the horizon, assuming it doesn't close before the end of this year. IonQ announced in November that it plans ...